Vladimir Sherbukhin

Title: Vladimir Sherbukhin: Innovator in Estrogen Receptor Compounds

Introduction

Vladimir Sherbukhin is a notable inventor based in Bronshoj, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with estrogen receptors. With a total of 2 patents, his work is pivotal in advancing treatment methods for various diseases and disorders.

Latest Patents

Sherbukhin's latest patents focus on novel di-aromatic compounds with activity at estrogen receptors. The first patent discloses methods for the treatment and prevention of diseases related to estrogen receptors by administering these innovative compounds to patients in need. The second patent elaborates on the use of these di-aromatic compounds for similar therapeutic purposes, showcasing their potential in medical applications.

Career Highlights

Vladimir Sherbukhin is currently associated with Acadia Pharmaceuticals Inc., where he continues to push the boundaries of pharmaceutical research. His expertise in estrogen receptor activity has positioned him as a key player in the development of new treatment options.

Collaborations

Sherbukhin collaborates with esteemed colleagues such as Roger Olsson and Lene Hyldtoft, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Vladimir Sherbukhin's work in the field of estrogen receptor compounds exemplifies the impact of innovative research in pharmaceuticals. His contributions are vital for the advancement of treatment methodologies, and his patents reflect a commitment to improving patient care.